PROJECT LIGHTHOUSE
Open
Human clinical trials for age-reversal therapies (epigenetic reprogramming) will begin within a few years (by ~2029–2030), starting with specific tissues.
- Expert
- David Friedberg
- Prediction date
- Aug 31, 2026
- Deadline
- Dec 31, 2030
- Category
- Science & Space
- Explicit confidence
- Not stated
Original statement
“His prediction: human therapy trials for age reversal will begin within the next few years, initially targeting specific tissues like the retina and heart before addressing aging systemically.”
Normalized claim
Human clinical trials for age-reversal therapies (epigenetic reprogramming) will begin within a few years (by ~2029–2030), starting with specific tissues.
A falsifiable interpretation, separate from the exact source text.
Resolution criteria
ClinicalTrials.gov or peer-reviewed announcements of human trials using epigenetic reprogramming or equivalent age-reversal approaches by 2030.
Market context
No high-confidence matching market is linked. Loose thematic matches are not shown.
Resolution
This prediction remains open.
Audit trailView full history
- Source recorded2026-08-31 00:00 UTC
- Prediction verified and frozen2026-09-11 04:28 UTC